
    
      This is a two-year open-label, randomized trial of the comparative effectiveness of clozapine
      versus olanzapine in patients with treatment refractory schizophrenia. The objective is to
      determine whether in a naturalistic setting olanzapine is a logical treatment choice (before
      using the more toxic clozapine) for some treatment refractory patients.
    
  